These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 15192020)
21. Roles of STAT3 defined by tissue-specific gene targeting. Akira S Oncogene; 2000 May; 19(21):2607-11. PubMed ID: 10851059 [TBL] [Abstract][Full Text] [Related]
22. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart. Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800 [TBL] [Abstract][Full Text] [Related]
23. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. Berthod F; Germain L; Tremblay N; Auger FA J Cell Physiol; 2006 May; 207(2):491-8. PubMed ID: 16453301 [TBL] [Abstract][Full Text] [Related]
24. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990 [TBL] [Abstract][Full Text] [Related]
25. STAT3: a critical transcription activator in angiogenesis. Chen Z; Han ZC Med Res Rev; 2008 Mar; 28(2):185-200. PubMed ID: 17457812 [TBL] [Abstract][Full Text] [Related]
26. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy. Swinnen M; Vanhoutte D; Van Almen GC; Hamdani N; Schellings MW; D'hooge J; Van der Velden J; Weaver MS; Sage EH; Bornstein P; Verheyen FK; VandenDriessche T; Chuah MK; Westermann D; Paulus WJ; Van de Werf F; Schroen B; Carmeliet P; Pinto YM; Heymans S Circulation; 2009 Oct; 120(16):1585-97. PubMed ID: 19805649 [TBL] [Abstract][Full Text] [Related]
27. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Sekine H; Shimizu T; Hobo K; Sekiya S; Yang J; Yamato M; Kurosawa H; Kobayashi E; Okano T Circulation; 2008 Sep; 118(14 Suppl):S145-52. PubMed ID: 18824746 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury. Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839 [TBL] [Abstract][Full Text] [Related]
30. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Boengler K; Buechert A; Heinen Y; Roeskes C; Hilfiker-Kleiner D; Heusch G; Schulz R Circ Res; 2008 Jan; 102(1):131-5. PubMed ID: 17967780 [TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. Dawn B; Guo Y; Rezazadeh A; Wang OL; Stein AB; Hunt G; Varma J; Xuan YT; Wu WJ; Tan W; Zhu X; Bolli R J Mol Cell Cardiol; 2004 Jul; 37(1):51-61. PubMed ID: 15242735 [TBL] [Abstract][Full Text] [Related]
32. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061 [TBL] [Abstract][Full Text] [Related]
33. Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury. Penumathsa SV; Koneru S; Thirunavukkarasu M; Zhan L; Prasad K; Maulik N J Pharmacol Exp Ther; 2007 Feb; 320(2):951-9. PubMed ID: 17132814 [TBL] [Abstract][Full Text] [Related]
34. The myocardial JAK/STAT pathway: from protection to failure. Boengler K; Hilfiker-Kleiner D; Drexler H; Heusch G; Schulz R Pharmacol Ther; 2008 Nov; 120(2):172-85. PubMed ID: 18786563 [TBL] [Abstract][Full Text] [Related]
35. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294 [TBL] [Abstract][Full Text] [Related]
37. STAT3, a key regulator of cell-to-cell communication in the heart. Haghikia A; Ricke-Hoch M; Stapel B; Gorst I; Hilfiker-Kleiner D Cardiovasc Res; 2014 May; 102(2):281-9. PubMed ID: 24518140 [TBL] [Abstract][Full Text] [Related]